-+ 0.00%
-+ 0.00%
-+ 0.00%

China Biopharmaceutical: The Phase III registered clinical trial of TQC2731 injection “TSLP monoclonal antibody” for maintenance treatment of chronic sinusitis with nasal polyps completed the enrollment of all participants.

Zhitongcaijing·10/21/2026 00:01:02
Listen to the news
China Biopharmaceutical: The Phase III registered clinical trial of TQC2731 injection “TSLP monoclonal antibody” for maintenance treatment of chronic sinusitis with nasal polyps completed the enrollment of all participants.